| Amber Anderson, | |
|
601 Benton Ave, Nashville, TN 37204-2303 | |
| (615) 292-9770 | |
| Not Available |
| Full Name | Amber Anderson |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 601 Benton Ave, Nashville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073161774 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (Tennessee) | Primary |
| Entity Name | University Community Health Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275634818 PECOS PAC ID: 9234035809 Enrollment ID: O20031212000389 |
News Archive
In just three months, demand for lab and office space at the Johns Hopkins innovation hub, FastForward East, has exceeded supply. The FastForward program, designed to move academic findings through translational research into the commercial marketplace, was introduced to East Baltimore earlier this year in an interim facility in the Rangos Building at 855 N. Wolfe St. In that time, all of its offices and lab benches have been rented.
Elderly women with early-stage breast cancer live longer with radiation therapy and surgery compared with surgery alone, researchers at the University of Maryland School of Medicine have found.
Researchers from the Universitat Oberta de Catalunya (UOC) and the technology centre Eurecat have developed an innovative formal representation of rare disease data, including information unavailable in current models on the rare disease patient's biological, psychological and social profile.
Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.
A technique to treat an irregular heartbeat that limits or eliminates patients' exposure to radiation should be more widely adopted by physicians, NewYork-Presbyterian and Weill Cornell Medicine cardiologists argue in a new review article in Heart Rhythm, published in the June print issue and previously published online.
› Verified 3 days ago
| Entity Name | Diana Health Tn, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457020844 PECOS PAC ID: 4688065980 Enrollment ID: O20211221001806 |
News Archive
In just three months, demand for lab and office space at the Johns Hopkins innovation hub, FastForward East, has exceeded supply. The FastForward program, designed to move academic findings through translational research into the commercial marketplace, was introduced to East Baltimore earlier this year in an interim facility in the Rangos Building at 855 N. Wolfe St. In that time, all of its offices and lab benches have been rented.
Elderly women with early-stage breast cancer live longer with radiation therapy and surgery compared with surgery alone, researchers at the University of Maryland School of Medicine have found.
Researchers from the Universitat Oberta de Catalunya (UOC) and the technology centre Eurecat have developed an innovative formal representation of rare disease data, including information unavailable in current models on the rare disease patient's biological, psychological and social profile.
Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.
A technique to treat an irregular heartbeat that limits or eliminates patients' exposure to radiation should be more widely adopted by physicians, NewYork-Presbyterian and Weill Cornell Medicine cardiologists argue in a new review article in Heart Rhythm, published in the June print issue and previously published online.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amber Anderson, 601 Benton Ave, Nashville, TN 37204-2303 Ph: (615) 292-9770 | Amber Anderson, 601 Benton Ave, Nashville, TN 37204-2303 Ph: (615) 292-9770 |
News Archive
In just three months, demand for lab and office space at the Johns Hopkins innovation hub, FastForward East, has exceeded supply. The FastForward program, designed to move academic findings through translational research into the commercial marketplace, was introduced to East Baltimore earlier this year in an interim facility in the Rangos Building at 855 N. Wolfe St. In that time, all of its offices and lab benches have been rented.
Elderly women with early-stage breast cancer live longer with radiation therapy and surgery compared with surgery alone, researchers at the University of Maryland School of Medicine have found.
Researchers from the Universitat Oberta de Catalunya (UOC) and the technology centre Eurecat have developed an innovative formal representation of rare disease data, including information unavailable in current models on the rare disease patient's biological, psychological and social profile.
Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.
A technique to treat an irregular heartbeat that limits or eliminates patients' exposure to radiation should be more widely adopted by physicians, NewYork-Presbyterian and Weill Cornell Medicine cardiologists argue in a new review article in Heart Rhythm, published in the June print issue and previously published online.
› Verified 3 days ago
Mrs. Lydia Kelly, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Nicole Mercer, NP-C, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Megan Donohue, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Letitia C Rainey, APN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 5201 Charlotte Ave, Nashville, TN 37209 Phone: 615-222-1900 Fax: 615-222-1917 | |
Sabyl Elena Farmer, APRN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Sierra Mcgowan, APRN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Kameron D Brainard, CNM, APN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 |